Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy

Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy

Bibliographic Details
Main Authors:	Federica Cappuccini, Emily Pollock, Irina Redchenko, Benoit J Van den Eynde, James McAuliffe, Hok Fung Chan, Laurine Noblecourt, Ramiro Andrei Ramirez-Valdez, Vinnycius Pereira-Almeida, Yaxuan Zhou, Adrian VS Hill, Carol Sze Ki Leung
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2021-09-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/9/9/e003218.full

Similar Items

Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy
by: McAuliffe, J, et al.
Published: (2021)

835 Heterologous prime boost viral vector vaccination provides protection against intracranial syngeneic murine glioblastoma
by: Mark Gilbert, et al.
Published: (2023-11-01)

Developing viral vectored vaccines for MAGE-expressing tumours
by: McAuliffe, J
Published: (2020)

Intravenous heterologous prime-boost vaccination activates innate and adaptive immunity to promote tumor regression
by: Ramiro A. Ramirez-Valdez, et al.
Published: (2023-06-01)

5T4 oncofoetal glycoprotein: an old target for a novel prostate cancer immunotherapy
by: Cappuccini, F, et al.
Published: (2017)

Developing a personalized heterologous prime boost vaccination strategy for tumor therapy
by: Ramirez-Valdez, RA
Published: (2021)

Images du Mage, images pour le Mage
by: Daniel Grégorio

Intravenous heterologous prime-boost vaccination activates innate and adaptive immunity to promote tumor regression
by: Ramirez-Valdez, RA, et al.
Published: (2023)

Microbe Mage
by: Rosli, Nur Ezzati, et al.
Published: (2017)

Frequent MAGE mutations in human melanoma.
by: Caballero, O, et al.
Published: (2010)

Frequent MAGE mutations in human melanoma.
by: Otavia L Caballero, et al.
Published: (2010-01-01)

Advances in maging and electron physics.
by: Hawkes, Peter W., editor
Published: (2014)

MAGE SCHEMATIC ACCOUNT OF TRANSLATION
by: WANG Bin
Published: (2007-01-01)

mage of Tamerlane in the Tale of Temir Aksak
by: Lyapin D.A.
Published: (2022-03-01)

Progress in DNA-based heterologous prime-boost immunization strategies for malaria.
by: Moore, A, et al.
Published: (2004)

Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data
by: Shaw, RH, et al.
Published: (2021)

Heterologous prime-boost vaccination against COVID-19: is it safe and reliable?
by: Om Prakash Choudhary, et al.
Published: (2021-12-01)

Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine
by: Thuy Trang Nguyen, et al.
Published: (2022-03-01)

Enhanced T-Cell Priming and Improved Anti-Tumor Immunity through Lymphatic Delivery of Checkpoint Blockade Immunotherapy
by: Carolina Mantilla-Rojas, et al.
Published: (2022-04-01)

The lost gate : a novel of the Mither mages /
by: 309218 Card, Orson Scott
Published: (c201)

JPEG mage encryption with Elliptic Curve Cryptography
by: Bakhtiari, S., et al.
Published: (2015)

Statskundskab og journalistik – et mage par?
by: Erik Albæk
Published: (2006-07-01)

J. Magee, The Belgians in Ontario. A History
by: C. Pansaerts
Published: (1991-01-01)

Correction: Frequent MAGE Mutations in Human Melanoma
Published: (2010-01-01)

L’entretien par le mage préventif
by: Ivan Illich
Published: (2014-06-01)

Statskundskab og journalistik – et mage par?
by: Erik Albæk
Published: (2006-07-01)

The XBabelPhish MAGE-ML and XML Translator
by: Sherlock Gavin, et al.
Published: (2008-01-01)

<i>MAGE-C1</i> gene and mage-c1 protein expression comparison in primary multiple myeloma patients
by: E. A. Makunina, et al.
Published: (2022-04-01)

Kloning Gen Melanoma Antigen 1 (Mage-1) dari Jaringan Testis untuk mendapatkan Plasmid Rekombinan Mage-1
by: Gondo Mastutik, et al.
Published: (2015-12-01)

Expression of MAGE-C1/CT7 and MAGE-C2/CT10 predicts lymph node metastasis in melanoma patients.
by: Alessandra Curioni-Fontecedro, et al.
Published: (2011-01-01)

DNA-based vaccines for malaria: a heterologous prime-boost immunisation strategy.
by: Hill, A, et al.
Published: (2000)

Induction of CD8+ T cells using heterologous prime-boost immunisation strategies.
by: Schneider, J, et al.
Published: (1999)

Heterologous prime-boost vaccination protects against EBV antigen-expressing lymphomas.
by: Rühl, J, et al.
Published: (2019)

Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIV
by: Ros Chapman, et al.
Published: (2021-11-01)

Is heterologous prime-boost COVID-19 vaccination a concern or an opportunity for Ethiopia?
by: Tesfaye Gelanew, et al.
Published: (2023-01-01)

Heterologous prime-boost: an important candidate immunization strategy against Tembusu virus
by: Yuting Pan, et al.
Published: (2020-05-01)

Exploring heterologous prime-boost vaccination approaches to enhance influenza control in pigs
by: Chong Li, et al.
Published: (2020-07-01)

826 Differential effect of NKG2A blockade on peripheral and intra-tumoral CD8 T cell response induced by KISIMA – VSV-GP-TAg heterologous prime-boost vaccination
by: Matteo Rossi, et al.
Published: (2023-11-01)

The multi-mode acoustic gravitational wave experiment: MAGE
by: William M. Campbell, et al.
Published: (2023-06-01)

Expanding the landscape of TCR gene therapy targeting MAGE
by: Zhiyuan Mao, et al.
Published: (2023-06-01)